Insomnia drug therapy in COVID-19 patients; a letter to editor

Abstract

Caspian J Intern Med 2020; 11(Suppl 1): S583-584 Insomnia drug therapy in COVID-19 patients 583 Caspian J Intern Med 2020; 11(Suppl1):S583-584 DOI: 10.22088/cjim.11.0.583 Letter to Editor Insomnia drug therapy in COVID-19 patients; a letter to editor Dear Sir, Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by the newly emerging SARS- CoV-2 virus that was first reported in December 2019 and was announced as a pandemic disease on March 11th, according to a World Health Organization (WHO) warning (1). COVID-19 requires treatment in isolation because of its transmission through respiratory droplets and close contact. It has been reported that many patients developed sleep disturbances due to isolation treatment or medication use and need to prescribe hypnotic medications (2). Also, some patients may have taken hypnotic medications before developing COVID-19 and may already be dependent on these medications, and now, with the onset of COVID-19 and the addition of new drugs for its treatment, they need to change their hypnotic medications.